Unique patterns of surface receptors, cytokine secretion, and immune functions distinguish T cells in the bone marrow from those in the periphery: impact on allogeneic bone marrow transplantation

被引:62
作者
Zeng, DF
Hoffmann, P
Lan, FS
Huie, P
Higgins, J
Strober, S
机构
[1] Stanford Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol,Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
关键词
D O I
10.1182/blood.V99.4.1449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The "conventional" NK1.1(-) T cells from mouse blood and marrow were compared with regard to surface receptors, cytokine secretion, and function. Most blood NK1.1(-) CD4(+) and CD8(+) T cells expressed the naive CD44(int/lo)CD62L(hi)CD45RB(hi) T-cell phenotype typical of those in the peripheral lymphoid tissues. In contrast, most marrow NK1.1(-) CD4(+) and CD8(+) T cells expressed an unusual CD44(hi)CD62L(hi)CD45RB(hi) phenotype. The blood NK1.1(-) CD4(+) T cells had a naive T-helper cytokine profile and a potent capacity to induce lethal graft versus host (GVH) disease in a C57BL/6 donor to a BALB/c host bone marrow transplantation model. In contrast, the marrow NK1.1(-) CD4(+) T cells had a 'Th0 cytokine profile and failed to induce lethal GVH disease, even at 20-fold higher numbers than those from the blood. NK1.1(-) CD8(+) T cells from the blood but not the marrow induced lethal GVH disease. Nevertheless, the marrow NK1.1(-) CD8(+) T cells induced potent antitumor activity that was augmented by marrow NK1.1(-) CD4(+) T cells and facilitated hematopoietic progenitor engraftment. The inability of marrow CD4(+) and CD8(+) T cells to induce GVH disease was associated with their inability to expand in the blood and gut of allogeneic recipients. Because neither the purified marrow CD4+ or CD8+ T cells induced GVH disease, their unique features are desirable for inclusion in allogeneic bone marrow or hematopoietic progenitor transplants. (C) 2002 by The American Society of Hematology.
引用
收藏
页码:1449 / 1457
页数:9
相关论文
共 30 条
  • [1] Expansion of cytolytic CD8+ natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production
    Baker, J
    Verneris, MR
    Ito, M
    Shizuru, JA
    Negrin, RS
    [J]. BLOOD, 2001, 97 (10) : 2923 - 2931
  • [2] TH0 CELLS IN THE THYMUS - THE QUESTION OF T-HELPER LINEAGES
    BENDELAC, A
    SCHWARTZ, RH
    [J]. IMMUNOLOGICAL REVIEWS, 1991, 123 : 169 - 188
  • [3] Mouse CD1-specific NK1 T cells: Development, specificity, and function
    Bendelac, A
    Rivera, MN
    Park, SH
    Roark, JH
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 535 - 562
  • [4] Regulation of extrathymic T cell development and turnover by oncostatin M
    Boileau, C
    Houde, M
    Dulude, G
    Clegg, CH
    Perreault, C
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (11) : 5713 - 5720
  • [5] Identification of an early T cell progenitor for a pathway of T cell maturation in the bone marrow
    Dejbakhsh-Jones, S
    Strober, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (25) : 14493 - 14498
  • [6] Eberl G, 1999, J IMMUNOL, V162, P6410
  • [7] The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery
    Ernst, B
    Lee, DS
    Chang, JM
    Sprent, J
    Surh, CD
    [J]. IMMUNITY, 1999, 11 (02) : 173 - 181
  • [8] Fowler DH, 1996, J IMMUNOL, V157, P4811
  • [9] CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers
    Gandy, KL
    Domen, J
    Aguila, H
    Weissman, IL
    [J]. IMMUNITY, 1999, 11 (05) : 579 - 590
  • [10] An alternate pathway for T cell development supported by the bone marrow microenvironment:: Recapitulation of thymic maturation
    García-Ojeda, ME
    Dejbakhsh-Jones, S
    Weissman, IL
    Strober, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) : 1813 - 1823